This list is an analysis based on recent market events. It's not an investment recommendation.
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
FAQs
What is Lin BioScience stock price today?▼
The current price of 6696.TWO is TWD159.00 TWD — it has decreased by -0.93% in the past 24 hours. Watch Lin BioScience stock price performance more closely on the chart.
What is Lin BioScience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Lin BioScience stocks are traded under the ticker 6696.TWO.
Is Lin BioScience stock price growing?▼
6696.TWO stock has fallen by -0.62% compared to the previous week, the month change is a -12.12% fall, over the last year Lin BioScience has showed a +450% increase.
What is Lin BioScience market cap?▼
Today Lin BioScience has the market capitalization of 13.17B
What is Lin BioScience revenue for the last year?▼
Lin BioScience revenue for the last year amounts to 0 TWD.
What is Lin BioScience net income for the last year?▼
6696.TWO net income for the last year is -1.36B TWD.
How many employees does Lin BioScience have?▼
As of November 4, 2026, the company has 20 employees.
In which sector is Lin BioScience located?▼
Lin BioScience operates in the Health & Wellness sector.
When did Lin BioScience complete a stock split?▼
The last stock split for Lin BioScience was on August 20, 2026 with a ratio of 10000:1000.
Where is Lin BioScience headquartered?▼
Lin BioScience is headquartered in Taipei, Taiwan.